GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 1 filers reported holding GENOMIC HEALTH INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $14,000 | +16.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $12,000 | -14.3% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $14,000 | +7.7% | 200 | 0.0% | 0.00% | -20.0% |
| Q4 2018 | $13,000 | -7.1% | 200 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $14,000 | +40.0% | 200 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $10,000 | +66.7% | 200 | 0.0% | 0.01% | +66.7% |
| Q1 2018 | $6,000 | -14.3% | 200 | 0.0% | 0.00% | -25.0% |
| Q4 2017 | $7,000 | +16.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $6,000 | -14.3% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $7,000 | +16.7% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $6,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $6,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $6,000 | +20.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $5,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $5,000 | -28.6% | 200 | 0.0% | 0.00% | -20.0% |
| Q4 2015 | $7,000 | +75.0% | 200 | 0.0% | 0.01% | +66.7% |
| Q3 2015 | $4,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,000,000 | $56,620,000 | 5.32% |
| Baker Brothers Advisors | 13,655,618 | $386,590,000 | 4.87% |
| NORTH TIDE CAPITAL, LLC | 1,500,000 | $42,465,000 | 3.24% |
| Murphy Michael R | 291,292 | $8,246,000 | 2.85% |
| Tributary Capital Management, LLC | 111,244 | $3,149,000 | 0.66% |
| Champlain Investment Partners, LLC | 1,234,780 | $34,957,000 | 0.61% |
| IRONBRIDGE CAPITAL MANAGEMENT LP | 454,085 | $12,855,000 | 0.34% |
| STONEBRIDGE CAPITAL MANAGEMENT INC | 27,180 | $769,000 | 0.30% |
| Motley Fool Asset Management LLC | 36,179 | $1,139,000 | 0.24% |
| Kimelman & Baird, LLC | 35,800 | $1,013,000 | 0.19% |